Catalyst Wire Dossier Catalyst Wire Dossier

AUBAGIO

TERIFLUNOMIDE · Genzyme Corporation
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for AUBAGIO, covering 2012-03-01 to 2026-02-11. Get the full timeline:

Most recent: FDA Approved: AUBAGIO — Supplemental Application (Genzyme Corporation)

See pricing